Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-14.30 Insider Own4.62% Shs Outstand0.89M Perf Week-7.05%
Market Cap4.29M Forward P/E- EPS next Y-5.46 Insider Trans28.05% Shs Float0.85M Perf Month-15.38%
Income-8.85M PEG- EPS next Q-3.87 Inst Own7.82% Short Float8.48% Perf Quarter-31.21%
Sales0.64M P/S6.70 EPS this Y27.85% Inst Trans- Short Ratio0.18 Perf Half Y-34.40%
Book/sh3.29 P/B1.46 EPS next Y48.07% ROA-70.86% Short Interest0.07M Perf Year-51.24%
Cash/sh5.82 P/C0.83 EPS next 5Y- ROE-168.56% 52W Range4.29 - 14.44 Perf YTD-40.11%
Dividend Est.- P/FCF- EPS past 5Y63.34% ROI-374.68% 52W High-66.66% Beta1.56
Dividend TTM- Quick Ratio3.64 Sales past 5Y33.74% Gross Margin-8.70% 52W Low12.24% ATR (14)0.40
Dividend Ex-Date- Current Ratio3.88 EPS Y/Y TTM88.14% Oper. Margin-1905.12% RSI (14)32.96 Volatility4.62% 7.09%
Employees22 Debt/Eq0.03 Sales Y/Y TTM-18.17% Profit Margin-1374.22% Recom1.00 Target Price19.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q82.98% Payout- Rel Volume0.04 Prev Close4.98
Sales Surprise-46.34% EPS Surprise61.04% Sales Q/Q-52.48% EarningsMar 28 AMC Avg Volume405.54K Price4.82
SMA20-15.39% SMA50-15.30% SMA200-34.44% Trades Volume17,231 Change-3.31%
Date Action Analyst Rating Change Price Target Change
Mar-24-21Initiated Noble Capital Markets Outperform $20
Apr-24-24 09:05AM
Apr-03-24 07:05AM
Apr-01-24 12:18PM
Mar-28-24 04:05PM
Mar-15-24 07:05AM
08:59AM Loading…
Mar-12-24 08:59AM
Mar-07-24 07:00AM
Mar-04-24 07:00AM
Feb-06-24 07:00AM
Feb-05-24 07:05AM
Jan-11-24 07:00AM
Dec-07-23 09:55AM
Nov-30-23 07:47AM
Nov-13-23 11:07AM
Nov-09-23 04:05PM
07:05AM Loading…
Nov-06-23 07:05AM
Nov-02-23 05:05PM
Oct-20-23 02:34PM
Oct-12-23 07:05AM
Oct-02-23 07:05AM
Sep-28-23 07:00AM
Sep-21-23 07:05AM
Sep-20-23 07:05AM
Sep-13-23 07:05AM
Sep-06-23 09:55AM
Sep-05-23 07:00AM
Aug-16-23 09:00AM
Aug-13-23 08:13AM
Aug-11-23 07:33AM
Aug-10-23 06:15PM
04:05PM Loading…
Aug-07-23 07:05AM
Aug-02-23 04:05PM
Jul-27-23 07:05AM
Jun-20-23 07:05AM
Jun-14-23 04:05PM
May-25-23 07:05AM
May-24-23 07:05AM
May-19-23 05:00PM
May-16-23 12:14PM
May-12-23 06:31AM
May-11-23 04:05PM
May-04-23 04:05PM
Apr-17-23 07:05AM
Apr-16-23 06:30AM
Mar-24-23 12:29PM
Mar-23-23 05:00PM
Mar-22-23 07:05AM
Mar-10-23 06:22AM
Mar-09-23 04:05PM
Mar-06-23 07:30AM
Mar-02-23 04:05PM
Feb-15-23 07:05AM
Jan-23-23 07:05AM
Jan-19-23 09:00AM
Jan-10-23 07:05AM
Jan-05-23 07:41AM
Jan-03-23 07:05AM
Dec-30-22 04:05PM
Nov-17-22 12:00PM
Nov-14-22 06:30AM
Nov-09-22 07:05AM
Nov-08-22 07:05AM
Nov-03-22 07:05AM
Nov-01-22 07:05AM
Oct-13-22 07:05AM
Sep-29-22 05:20PM
Sep-14-22 05:05PM
Sep-06-22 06:30AM
Aug-18-22 12:00PM
Aug-15-22 04:05PM
Aug-10-22 07:05AM
Aug-05-22 08:38AM
Jul-15-22 10:55AM
Jul-12-22 07:05AM
Jun-17-22 12:00PM
Jun-06-22 07:05AM
Jun-01-22 07:05AM
May-31-22 08:36AM
May-24-22 04:05PM
May-17-22 07:30AM
May-12-22 06:50AM
May-03-22 07:05AM
Apr-27-22 07:05AM
Apr-26-22 07:05AM
Mar-14-22 04:05PM
Feb-17-22 05:20PM
Jan-26-22 04:30PM
Dec-20-21 05:00PM
Dec-17-21 07:05AM
Dec-14-21 07:05AM
Dec-06-21 07:05AM
Nov-15-21 11:49AM
Nov-12-21 04:05PM
Nov-10-21 04:05PM
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM